1. Home
  2. GIXI vs GDTC Comparison

GIXI vs GDTC Comparison

Compare GIXI & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gix Internet Ltd. Ordinary Shares

GIXI

Gix Internet Ltd. Ordinary Shares

N/A

Current Price

$4.05

Market Cap

9.7M

Sector

Technology

ML Signal

N/A

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

N/A

Current Price

$0.92

Market Cap

10.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GIXI
GDTC
Founded
1978
2018
Country
Israel
Singapore
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7M
10.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GIXI
GDTC
Price
$4.05
$0.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.3M
16.8K
Earning Date
11-30-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.56
$0.68
52 Week High
$8.34
$3.10

Technical Indicators

Market Signals
Indicator
GIXI
GDTC
Relative Strength Index (RSI) 39.34 50.22
Support Level $3.79 $0.73
Resistance Level $8.34 $1.07
Average True Range (ATR) 0.72 0.11
MACD 0.03 -0.00
Stochastic Oscillator 7.53 53.71

Price Performance

Historical Comparison
GIXI
GDTC

About GIXI Gix Internet Ltd. Ordinary Shares

Gix Internet Ltd provides infrastructure for managing and authorizing autonomous systems, including autonomous mobile robots (AMRs), automated guided vehicles (AGVs), humanoid robots, robotaxis, shuttles, drones, and human workforces. The company's platform provides: mission generation and orchestration across mixed-fleet environments; real-time authorization and policy-gate enforcement for regulatory compliance; and cryptographically signed records of authorized actions for regulatory compliance.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: